What the market wants from AMBS is LymPro revenue, which is still a few months away..... or a LymPro JV Partnership! That has always been what gives AMBS it's value. When the market thinks a LymPro JV Partner is near, the pps creeps up. When those hopes are dashed, the pps falls. It's that simple.

MANF & Elto data announcements don't really pop us up.

I don't think management is very in tune with the market, they never have been. If they have a surprise announcement that pops our pps up, then great, the billion share vote won't hurt us much. If they don't have a big surprise, we will struggle till December when we get LymPro commercialization, the media blitz, and MANF orphans.